Drugmakers focus on AI while awaiting clarity on US tariffs
Drugmakers Turn to AI for Drug Development Amid US Tariff Uncertainty Pharmaceutical executives are increasingly turning to artificial intelligence (AI) as a key tool in accelerating drug development processes. The…